DBMR - Medical Devices

Global Biomarkers Market – Industry Trends - Forecast to 2026

  • Medical Devices
  • Published Report
  • Mar 2019
  • Global
  • 228 Pages
  • No of Tables: 67
  • No of Figures: 150
Global Biomarkers Market By Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Product Type (Consumables, Services, Software), Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Biomarkers Market

Global Biomarkers Market is expected to rise from its initial estimated value of USD 36.19 billion to an estimated value of USD 101.80 billion by 2026, registering a CAGR of 13.80% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing diagnostic applications of biomarkers.

Market Definition: Global Biomarkers Market

Biomarkers which is also known as molecular marker or signature molecule, is used to check that how body responds to a treatment of any condition or disease. In simple words, they are used to examine the organ functions and other health conditions. They are also used in the imaging technology so that they can provide clear imaging of oncology tumors and other problems. They are also used in clinical studies to determine the effect and results of drugs in early stage.

Market Drivers

  • Increasing usage of biomarkers in cancer treatment is driving the market growth.
  • R&D funding for pharma and biotech companies is increasing which is driving the biomarker market.

Market Restraints

  • Requirement of significant amount of funds is restraining the market growth.
  • Unfavorable regulatory and repayment policies are restraining the growth of this market.

Segmentation: Global Biomarkers Market

  • By Application

    •  Diagnostics Development
    •  Drug Discovery and Development
    •  Personalized Medicine
    •  Disease-Risk Assessment
    •  Others

  • By Product Type

    •  Consumables
    •  Services
    •  Software

  • By Technology

    •  Safety Biomarkers
    •  Efficacy Biomarkers

      • Predictive Biomarkers
      • Surrogate Biomarkers
      • Pharmacodynamics Biomarkers
      • Prognostic Biomarkers

    •  Validation Biomarkers

  • By Indication

    •  Cancer
    •  Cardiovascular Disorders
    •  Neurological Disorders
    •  Immunological Disorders
    •  Others),

  • By Geography

    • North America

      • US.
      • Canada
      • Mexico

    • South America

      • Brazil
      • Argentina
      • Rest of South America

    • Europe

      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe

    • Asia-Pacific

      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific

    • Middle East & Africa

      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Key Developments in the Market:

  • In November 2016, Insilico Medicine, Inc., announced the launch of Aging.AI 2.0 the blood biochemistry predictor for human age. It is better than the previous version Aging.AI 1.0 and covers more population group.
  • In February 2018, Evidation Health announced the launch of their new project DisCover which is a 10,000 person chronic pain study. The main aim is to use activity trackers, health apps, and other more traditional data point and develop a digital biomarkers for chronic pains.

Competitive Analysis:

Global biomarkers market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biomarkers market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the biomarkers market are MESO SCALE DIAGNOSTICS, LLC., EKF Diagnostics Holdings plc,  Enzo Biochem Inc., Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer Inc., QIAGEN, Agilent Technologies, Inc., Bruker, Epigenomics AG, General Electric Company, Nexus-Dx., LifeSign LLC, F. Hoffmann-La Roche Ltd.

Research Methodology: Global Biomarkers Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global biomarkers market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

TABLE OF CONTENTS GLOBAL BIOMARKERS MARKET

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY 1.2. MARKET DEFINITION 1.3. OVERVIEW OF GLOBAL BIOMARKERS MARKET 1.4. CURRENCY AND PRICING 1.5. LIMITATION 1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCES 2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. INCREASED USAGE OF BIOMARKERS IN CANCER TREATMENT 3.1.2. GROWING EFFORTS TOWARDS DRUG DISCOVERY 3.1.3. WIDE APPLICATION OF BIOMARKERS IN PERSONALIZED MEDICINE AND DIAGNOSTICS 3.1.4. INITIATIVES TAKEN TOWARDS BIOMARKER RESEARCH

3.2. RESTRAINTS

3.2.1. UNFAVOURABLE REIMBURSEMENT SYSTEMS 3.2.2. HIGH CAPITAL INVESTMENTS 3.2.3. HIGH COSTING INVOLVED IN SAMPLE COLLECTION AND STORAGE

3.3. OPPORTUNITIES

3.3.1. EMERGING ECONOMIES

3.4. CHALLENGES

3.4.1. DEMONSTRATING THE CLINICAL VALIDITY IN BIOMARKER-BASED TESTS

4. EXECUTIVE SUMMARY 5. PREMIUM INSIGHTS 6. GLOBAL BIOMARKERS MARKET, BY APPLICATION

6.1. OVERVIEW 6.2. DIAGNOSTICS DEVELOPMENT 6.3. DRUG DISCOVERY AND DEVELOPMENT 6.4. PERSONALIZED MEDICINE 6.5. DISEASE RISK ASSESSMENT 6.6. OTHERS

7. GLOBAL BIOMARKERS MARKET, BY PRODUCT TYPE

7.1. OVERVIEW 7.2. CONSUMABLES 7.3. SERVICES 7.4. SOFTWARE

8. GLOBAL BIOMARKERS MARKET, BY INDICATION

8.1. OVERVIEW 8.2. CANCER 8.3. CARDIOVASCULAR DISEASE 8.4. NEUROLOGICAL DISORDERS 8.5. IMMUNOLOGICAL DISORDERS 8.6. OTHERS

9. GLOBAL BIOMARKERS MARKET, BY TECHNOLOGY

9.1. OVERVIEW 9.2. SAFETY BIOMARKERS 9.3. EFFICACY BIOMARKERS 9.4. VALIDATION BIOMARKERS

10. GLOBAL BIOMARKERS MARKET, BY GEOGRAPHY

10.1. OVERVIEW

10.2. NORTH AMERICA

10.2.1. U.S. 10.2.2. CANADA 10.2.3. MEXICO

10.3. EUROPE

10.3.1. GERMANY 10.3.2. FRANCE 10.3.3. U.K. 10.3.4. ITALY 10.3.5. SPAIN 10.3.6. SWITZERLAND 10.3.7. NETHERLANDS 10.3.8. BELGIUM 10.3.9. RUSSIA 10.3.10. TURKEY 10.3.11. REST OF EUROPE

10.4. ASIA-PACIFIC

10.4.1. JAPAN 10.4.2. CHINA 10.4.3. INDIA 10.4.4. SOUTH KOREA 10.4.5. AUSTRALIA 10.4.6. SINGAPORE 10.4.7. THAILAND 10.4.8. MALAYSIA 10.4.9. INDONESIA 10.4.10. PHILIPPINES 10.4.11. REST OF ASIA-PACIFIC

10.5. SOUTH AMERICA

10.5.1. BRAZIL 10.5.2. REST OF SOUTH AMERICA

10.6. MIDDLE EAST AND AFRICA

10.6.1. SOUTH AFRICA 10.6.2. REST OF MIDDLE EAST AND AFRICA

11. GLOBAL BIOMARKERS MARKET, COMPANY LANDSCAPE

11.1. COMPANY SHARE ANALYSIS: GLOBAL 11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA 11.3. COMPANY SHARE ANALYSIS: EUROPE 11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12. COMPANY PROFILES

12.1. QIAGEN

12.1.1. COMPANY OVERVIEW 12.1.2. QIAGEN: REVENUE ANALYSIS 12.1.3. PRODUCT PORTFOLIO 12.1.4. RECENT DEVELOPMENTS

12.2. MERCK & CO. INC.

12.2.1. COMPANY OVERVIEW 12.2.2. MERCK & CO. INC.: REVENUE ANALYSIS 12.2.3. PRODUCT PORTFOLIO 12.2.4. RECENT DEVELOPMENTS

12.3. BIO-RAD LABORATORIES, INC.

12.3.1. COMPANY OVERVIEW 12.3.2. BIO-RAD LABORATORIES, INC.: REVENUE ANALYSIS 12.3.3. PRODUCT PORTFOLIO 12.3.4. RECENT DEVELOPMENTS

12.4. ENZO BIOCHEM, INC.

12.4.1. COMPANY OVERVIEW 12.4.2. ENZO BIOCHEM, INC.: REVENUE ANALYSIS 12.4.3. PRODUCT PORTFOLIO 12.4.4. RECENT DEVELOPMENTS

12.5. PERKINELMER INC.

12.5.1. COMPANY OVERVIEW 12.5.2. PERKINELMER INC.: REVENUE ANALYSIS 12.5.3. PRODUCT PORTFOLIO 12.5.4. RECENT DEVELOPMENTS

12.6. EKF DIAGNOSTICS

12.6.1. COMPANY OVERVIEW 12.6.2. EKF DIAGNOSTICS: REVENUE ANALYSIS 12.6.3. PRODUCT PORTFOLIO 12.6.4. RECENT DEVELOPMENTS

12.7. MESO SCALE DIAGNOSTICS, LLC

12.7.1. COMPANY OVERVIEW 12.7.2. MESO SCALE DIAGNOSTICS, LLC: COMPANY SNAPSHOT 12.7.3. PRODUCT PORTFOLIO 12.7.4. RECENT DEVELOPMENTS

12.8. SINGULEX, INC.

12.8.1. COMPANY OVERVIEW 12.8.2. SINGULEX, INC.: COMPANY SNAPSHOT 12.8.3. PRODUCT PORTFOLIO 12.8.4. RECENT DEVELOPMENTS

12.9. SIGNOSIS, INC.

12.9.1. COMPANY OVERVIEW 12.9.2. SIGNOSIS, INC.: COMPANY SNAPSHOT 12.9.3. PRODUCT PORTFOLIO 12.9.4. RECENT DEVELOPMENTS

12.10. CISBIO BIOASSAYS

12.10.1. COMPANY OVERVIEW 12.10.2. CISBIO BIOASSAYS: COMPANY SNAPSHOT 12.10.3. PRODUCT PORTFOLIO 12.10.4. RECENT DEVELOPMENTS

13. RELATED REPORTS

LIST OF TABLE GLOBAL BIOMARKERS MARKE

TABLE 1 GLOBAL BIOMARKERS MARKET, BY APPLICATION, 2015– 2024 (USD MILLION) TABLE 2 GLOBAL BIOMARKERS MARKET, DIAGNOSTIC DEVELOPMENT, BY REGION, 2015-2024 (USD MILLION) TABLE 3 GLOBAL BIOMARKERS MARKET, DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2015-2024 (USD MILLION) TABLE 4 GLOBAL BIOMARKERS MARKET, PERSONALIZED MEDICINE, BY REGION, 2015-2024 (USD MILLION) TABLE 5 GLOBAL BIOMARKERS MARKET, DISEASE RISK ASSESSMENT, BY REGION, 2015-2024 (USD MILLION) TABLE 6 GLOBAL BIOMARKERS MARKET, OTHERS, BY REGION, 2015-2024 (USD MILLION) TABLE 7 GLOBAL BIOMARKERS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION) TABLE 8 GLOBAL BIOMARKERS MARKET,CONSUMABLES, BY REGION, 2015-2024 (USD MILLION) TABLE 9 GLOBAL BIOMARKERS MARKET, SERVICES, BY REGION, 2015-2024 (USD MILLION) TABLE 10 GLOBAL BIOMARKERS MARKET, SOFTWARE, BY REGION, 2015-2024 (USD MILLION) TABLE 11 GLOBAL BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 12 GLOBAL BIOMARKERS MARKET, CANCER, BY REGION, 2015-2024 (USD MILLION) TABLE 13 GLOBAL BIOMARKERS MARKET, CARDIOVASCULAR DISORDERS, BY REGION, 2015-2024 (USD MILLION) TABLE 14 GLOBAL BIOMARKERS MARKET, NEUROLOGICAL DISORDERS, BY REGION, 2015-2024 (USD MILLION) TABLE 15 GLOBAL BIOMARKERS MARKET, IMMUNOLOGICAL DISORDERS, BY REGION, 2015-2024 (USD MILLION) TABLE 16 GLOBAL BIOMARKERS MARKET, OTHERS, BY REGION, 2015-2024 (USD MILLION) TABLE 17 GLOBAL BIOMARKERS MARKET, BY TECHNOLOGY, 2015– 2024 (USD MILLION) TABLE 18 GLOBAL SAFETY BIOMARKERS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 19 GLOBAL EFFICACY BIOMARKERS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 20 GLOBAL SAFETY BIOMARKERS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 21 GLOBAL BIOMARKERS MARKET, BY COUNTRY, 2015-2024, (USD MILLION) TABLE 22 NORTH AMERICA BIOMARKERS MARKET, BY COUNTRY, 2015-2024 (USD MILLION) TABLE 23 NORTH AMERICA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 24 NORTH AMERICA BIOMARKERS MARKET, BY TECHNOLOGY, 2015-2024 (USD MILLION) TABLE 25 NORTH AMERICA BIOMARKERS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 26 NORTH AMERICA BIOMARKERS MARKET, BY INDICATION, 2015-2024 (USD MILLION) TABLE 27 U.S. BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 28 U.S. BIOMARKERS MARKET, BY TECHNOLOGY, 2015-2024 (USD MILLION) TABLE 29 U.S. BIOMARKERS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 30 U.S. BIOMARKERS MARKET, BY INDICATION, 2015-2024 (USD MILLION) TABLE 31 CANADA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 32 CANADA BIOMARKERS MARKET, BY TECHNOLOGY, 2015-2024 (USD MILLION) TABLE 33 CANADA BIOMARKERS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 34 CANADA BIOMARKERS MARKET, BY INDICATION, 2015-2024 (USD MILLION) TABLE 35 MEXICO BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 36 MEXICO BIOMARKERS MARKET, BY TECHNOLOGY, 2015-2024 (USD MILLION) TABLE 37 MEXICO BIOMARKERS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 38 MEXICO BIOMARKERS MARKET, BY INDICATION, 2015-2024 (USD MILLION) TABLE 39 EUROPE BIOMARKERS MARKET, BY COUNTRY, 2015-2024,(USD MILLION) TABLE 40 EUROPE BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 41 EUROPE BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 42 EUROPE BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 43 EUROPE BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 44 GERMANY BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 45 GERMANY BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 46 GERMANY BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 47 GERMANY BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 48 FRANCE BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 49 FRANCE BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 50 FRANCE BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 51 FRANCE BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 52 U.K. BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 53 U.K. BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 54 U.K. BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 55 U.K. BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 56 ITALY BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 57 ITALY BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 58 ITALY BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 59 ITALY BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 60 SPAIN BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 61 SPAIN BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 62 SPAIN BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 63 SPAIN BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 64 SWITZERLAND BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 65 SWITZERLAND BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 66 SWITZERLAND BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 67 SWITZERLAND BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 68 NETHERLANDS BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 69 NETHERLANDS BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 70 NETHERLANDS BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 71 NETHERLANDS BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 72 BELGIUM BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 73 BELGIUM BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 74 BELGIUM BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 75 BELGIUM BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 76 RUSSIA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 77 RUSSIA BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 78 RUSSIA BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 79 RUSSIA BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 80 TURKEY BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 81 TURKEY BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 82 TURKEY BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 83 TURKEY BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 84 REST OF EUROPE BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 85 ASIA PACIFIC BIOMARKERS MARKET, BY COUNTRY, 2015-2024 (USD MILLION) TABLE 86 ASIA-PACIFIC BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 87 ASIA-PACIFIC BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 88 ASIA-PACIFIC BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 89 ASIA-PACIFIC BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 90 JAPAN BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 91 JAPAN BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 92 JAPAN BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 93 JAPAN BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 94 CHINA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 95 CHINA BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 96 CHINA BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 97 CHINA BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 98 INDIA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 99 INDIA BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 100 INDIA BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 101 INDIA BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 102 SOUTH KOREA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 103 SOUTH KOREA BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 104 SOUTH KOREA BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 105 SOUTH KOREA BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 106 AUSTRALIA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 107 AUSTRALIA BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 108 AUSTRALIA BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 109 AUSTRALIA BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 110 SINGAPORE BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 111 SINGAPORE BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 112 SINGAPORE BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 113 SINGAPORE BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 114 THAILAND BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 115 THAILAND BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 116 THAILAND BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 117 THAILAND BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 118 MALAYSIA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 119 MALAYSIA BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 120 MALAYSIA BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 121 MALAYSIA BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 122 INDONESIA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 123 INDONESIA BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 124 INDONESIA BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 125 INDONESIA BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 126 PHILIPPINES BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 127 PHILIPPINES BIOMARKERS MARKET, BY TECHNOLOGY, 2015 - 2024 (USD MILLION) TABLE 128 PHILIPPINES BIOMARKERS MARKET, BY APPLICATION 2015 - 2024 (USD MILLION) TABLE 129 PHILIPPINES BIOMARKERS MARKET, BY INDICATION 2015 - 2024 (USD MILLION) TABLE 130 REST OF ASIA-PACIFIC BIOMARKERS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION) TABLE 131 SOUTH AMERICA BIOMARKERS MARKET, BY COUNTRY, 2015-2024 (USD MILLION) TABLE 132 SOUTH AMERICA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 133 SOUTH AMERICA BIOMARKERS MARKET, BY TECHNOLOGY, 2015-2024 (USD MILLION) TABLE 134 SOUTH AMERICA BIOMARKERS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 135 SOUTH AMERICA BIOMARKERS MARKET, BY INDICATION, 2015-2024 (USD MILLION) TABLE 136 BRAZIL BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 137 BRAZIL BIOMARKERS MARKET, BY TECHNOLOGY, 2015-2024 (USD MILLION) TABLE 138 BRAZIL BIOMARKERS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 139 BRAZIL BIOMARKERS MARKET, BY INDICATION, 2015-2024 (USD MILLION) TABLE 140 BRAZIL BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 141 MIDDLE EAST AND AFRICA BIOMARKERS MARKET, BY COUNTRY, 2015-2024 (USD MILLION) TABLE 142 MIDDLE EAST AND AFRICA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 143 MIDDLE EAST AND AFRICA BIOMARKERS MARKET, BY TECHNOLOGY, 2015-2024 (USD MILLION) TABLE 144 MIDDLE EAST AND AFRICA BIOMARKERS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 145 MIDDLE EAST AND AFRICA BIOMARKERS MARKET, BY INDICATION, 2015-2024 (USD MILLION) TABLE 146 SOUTH AFRICA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION) TABLE 147 SOUTH AFRICA BIOMARKERS MARKET, BY TECHNOLOGY, 2015-2024 (USD MILLION) TABLE 148 SOUTH AFRICA BIOMARKERS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 149 SOUTH AFRICA BIOMARKERS MARKET, BY INDICATION, 2015-2024 (USD MILLION) TABLE 150 REST OF MIDDLE EAST AND AFRICA BIOMARKERS MARKET, BY PRODUCT TYPE, 2015-2024 (USD MILLION)

LIST OF FIGURES GLOBAL BIOMARKERS MARKET

FIGURE 1 GLOBAL BIOMARKERS MARKET: SEGMENTATION FIGURE 2 GLOBAL BIOMARKERS MARKET: DATA TRIANGULATION FIGURE 3 GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT FIGURE 4 GLOBAL BIOMARKERS MARKET : BOTTOM UP APPROACH FIGURE 5 GLOBAL BIOMARKERS MARKET :TOP DOWN APPROACH FIGURE 6 GLOBAL BIOMARKERS MARKET: INTERVIEW DEMOGRAPHICS FIGURE 7 GLOBAL BIOMARKERS MARKET: KEY INSIGHTS BY INDUSTRY EXPERTS FIGURE 8 DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL BIOMARKERS MARKET FIGURE 9 GLOBAL BIOMARKERS MARKET: SEGMENTATION FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR BIOMARKERS AND ASIA PACIFIC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD FROM 2017 TO 2024 FIGURE 11 INCREASED USAGE OF BIOMARKERS IN CANCER TREATMENT AND GROWING EFFORTS TOWARDS DRUG DISCOVERY IS EXPECTED TO DRIVE THE MARKET FOR BIOMARKERS MARKET IN THE FORECAST PERIOD 2017 TO 2024 FIGURE 12 CONSUMABLES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL BIOMARKERS MARKET IN 2017 & 2024 FIGURE 13 ASIA PACIFIC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR BIOMARKERS MANUFACTURERS IN THE FORECAST PERIOD FROM 2017 TO 2024 46 FIGURE 14 GLOBAL BIOMARKERS MARKET: BY APPLICATION, 2016 FIGURE 15 GLOBAL BIOMARKERS MARKET, DIAGNOSTIC DEVELOPMENT, BY REGION (2016) FIGURE 16 GLOBAL BIOMARKERS MARKET, DRUG DISCOVERY AND DEVELOPMENT, BY REGION (2016) FIGURE 17 GLOBAL BIOMARKERS MARKET, PERSONALIZED MEDICINE, BY REGION (2016) FIGURE 18 GLOBAL BIOMARKERS MARKET, DISEASE RISK ASSESSMENT, BY REGION (2016) FIGURE 19 GLOBAL BIOMARKERS MARKET, OTHERS, BY REGION (2016) FIGURE 20 GLOBAL BIOMARKERS MARKET: BY PRODUCT TYPE, 2016 FIGURE 21 GLOBAL BIOMARKERS MARKET, CONSUMABLES, BY REGION (2016) FIGURE 22 GLOBAL BIOMARKERS MARKET, SERVICES, BY REGION (2016) FIGURE 23 GLOBAL BIOMARKERS MARKET, SOFTWARE, BY REGION (2016) FIGURE 24 GLOBAL BIOMARKERS MARKET: BY INDICATION, 2016 FIGURE 25 GLOBAL BIOMARKERS MARKET, CANCER, BY REGION (2016) FIGURE 26 GLOBAL BIOMARKERS MARKET, CARDIOVASCULAR DISORDERS, BY REGION (2016) FIGURE 27 GLOBAL BIOMARKERS MARKET, NEUROLOGICAL DISORDERS, BY REGION (2016) FIGURE 28 GLOBAL BIOMARKERS MARKET, IMMUNOLOGICAL DISORDERS, BY REGION (2016) FIGURE 29 GLOBAL BIOMARKERS MARKET, OTHERS, BY REGION (2016) FIGURE 30 GLOBAL BIOMARKERS MARKET: BY TECHNOLOGY, 2016 FIGURE 31 GLOBAL BIOMARKERS MARKET, SAFETY BIOMARKERS, BY REGION (2016) FIGURE 32 GLOBAL BIOMARKERS MARKET, EFFICACY BIOMARKERS, BY REGION (2016) FIGURE 33 GLOBAL BIOMARKERS MARKET, VALIDATION BIOMARKERS, BY REGION (2016) FIGURE 34 GLOBAL BIOMARKERS MARKET SNAPSHOT (2016) FIGURE 35 GLOBAL BIOMARKERS MARKET: BY GEOGRAPHY (2016) FIGURE 36 GLOBAL BIOMARKERS MARKET:BY GEOGRAPHY (2017) FIGURE 37 GLOBAL BIOMARKERS MARKET: BY GEOGRAPHY (2016 & 2024) FIGURE 38 GLOBAL BIOMARKERS MARKET, BY PRODUCT TYPE (2017 & 2024) FIGURE 39 NORTH AMERICA BIOMARKERS MARKET SNAPSHOT (2016) FIGURE 40 NORTH AMERICA BIOMARKERS MARKET: BY COUNTRY (2016) FIGURE 41 NORTH AMERICA BIOMARKERS MARKET:BY COUNTRY (2017) FIGURE 42 NORTH AMERICA BIOMARKERS MARKET BY COUNTRY (2016 & 2024) FIGURE 43 NORTH AMERICA BIOMARKERS MARKET, BY PRODUCT TYPE (2017 & 2024) FIGURE 44 EUROPE BIOMARKERS MARKET: SNAPSHOT (2016) FIGURE 45 EUROPE BIOMARKERS MARKET: BY COUNTRY (2016) FIGURE 46 EUROPE BIOMARKERS MARKET:BY COUNTRY (2017) FIGURE 47 EUROPE BIOMARKERS MARKET:BY COUNTRY (2016 & 2024) FIGURE 48 EUROPE BIOMARKERS MARKET, BY PRODUCT TYPE (2017 & 2024) FIGURE 49 ASIA-PACIFIC BIOMARKERS MARKET: SNAPSHOT (2016) FIGURE 50 ASIA-PACIFIC BIOMARKERS MARKET: BY COUNTRY (2016) FIGURE 51 ASIA-PACIFIC BIOMARKERS MARKET:BY COUNTRY (2017) FIGURE 52 ASIA-PACIFIC BIOMARKERS MARKET:BY COUNTRY (2016 & 2024) FIGURE 53 ASIA-PACIFIC BIOMARKERS MARKET, BY PRODUCT TYPE (2017 & 2024) FIGURE 54 SOUTH AMERICA BIOMARKERS MARKET SNAPSHOT (2016) FIGURE 55 SOUTH AMERICA BIOMARKERS MARKET: BY COUNTRY (2016) FIGURE 56 SOUTH AMERICA BIOMARKERS MARKET:BY COUNTRY (2017) FIGURE 57 SOUTH AMERICA BIOMARKERS MARKET BY COUNTRY (2016 & 2024) FIGURE 58 SOUTH AMERICA BIOMARKERS MARKET, BY PRODUCT TYPE (2017 & 2024) FIGURE 59 MIDDLE EAST AND AFRICA BIOMARKERS MARKET SNAPSHOT (2016) FIGURE 60 MIDDLE EAST AND AFRICA BIOMARKERS MARKET: BY COUNTRY (2016) FIGURE 61 MIDDLE EAST AND AFRICA BIOMARKERS MARKET: BY COUNTRY (2017) FIGURE 62 MIDDLE EAST AND AFRICA BIOMARKERS MARKET BY COUNTRY (2016 & 2024) FIGURE 63 MIDDLE EAST AND AFRICA BIOMARKERS MARKET, BY PRODUCT TYPE (2017 & 2024) FIGURE 64 GLOBAL BIOMARKERS MARKET: COMPANY SHARE 2016 (%) FIGURE 65 NORTH AMERICA BIOMARKERS MARKET: COMPANY SHARE 2016 (%) FIGURE 66 EUROPE BIOMARKERS MARKET: COMPANY SHARE 2016 (%) FIGURE 67 ASIA-PACIFIC BIOMARKERS MARKET: COMPANY SHARE 2016 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART